Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

Clinical trial NCT03759392 · COMPLETED

Trial details

NCT number: NCT03759392
Sponsor: Cytokinetics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Heart Failure With Reduced Ejection Fraction

Start date: 2019-04-09
Primary completion: 2021-11-08
Enrollment: 276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.